FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

774271000168105: Irinotecan (Act) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) injection, 1 x 2 mL vial (containered trade product pack)


Status: current, Defined. Date: 30-Apr 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2955581000168118 Irinotecan (Act) (irinotecan hydrochloride trihydrate 40 mg / 2 mL) injection, 1 x 2 mL vial (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2955591000168115 Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial Is a containered trade product pack true Inferred relationship Some
Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial Is a Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial true Inferred relationship Some
Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial has TPUU Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial true Inferred relationship Some 1
Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial has container type vial true Inferred relationship Some
Irinotecan (Act) 40 mg/2 mL injection, 2 mL vial has TP Irinotecan (Act) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start